Construction of covalently coupled, concatameric dimers of 7TM receptors

References

• Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep 2004; 5:30–4.
   PubMed Web of Science ®Google Scholar
• Gurevich VV, Gurevich EV. GPCR monomers and oligomers: it takes all kinds. Trends Neurosci 2008;31:74–81.
   PubMed Web of Science ®Google Scholar
• Ferrė S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, Waldhoer M, Woods AS, Franco R. Building a new conceptual framework for receptor heteromers. Nat Chem Biol 2009;5:131–4.
   PubMed Web of Science ®Google Scholar
• Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000;407:971–7.
   PubMed Web of Science ®Google Scholar
• White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998;396:679–82.
   PubMed Web of Science ®Google Scholar
• Pagano A, Rovelli G, Mosbacher J, Lohmann T, Duthey B, Stauffer D, Ristig D, Schuler V, Meigel I, Lampert C, Stein T, Prezeau L, Blahos J, Pin J, Froestl W, Kuhn R, Heid J, Kaupmann K, Bettler B. C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J Neurosci 2001;21:1189–202.
   PubMed Web of Science ®Google Scholar
• Margeta-Mitrovic M, Jan YN, Jan LY. Function of GB1 and GB2 subunits in G protein coupling of GABA(B) receptors. Proc Natl Acad Sci U S A 2001;98:14649–54.
   PubMed Web of Science ®Google Scholar
• Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, Prezeau L, Pin JP. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J 2001;20:2152–9.
   PubMed Web of Science ®Google Scholar
• Binet V, Goudet C, Brajon C, Le Corre L, Acher F, Pin JP, Prezeau L. Molecular mechanisms of GABA(B) receptor activation: new insights from the mechanism of action of CGP7930, a positive allosteric modulator. Biochem Soc Trans 2004;32:871–2.
   PubMed Web of Science ®Google Scholar
• Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001;2:274–86.
   PubMed Web of Science ®Google Scholar
• Milligan G. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 2004;66:1–7.
   PubMed Web of Science ®Google Scholar
• Dalrymple MB, Pfleger KD, Eidne KA. G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther 2008;118:359–71.
   PubMed Web of Science ®Google Scholar
• Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M, Marullo S. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 2002;277:34666–73.
   PubMed Web of Science ®Google Scholar
• Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, Bouvier M. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 2003;17:677–91.
   PubMed Web of Science ®Google Scholar
• Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, Bouvier M. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 2004;279:33390–7.
   PubMed Web of Science ®Google Scholar
• Herrick-Davis K, Weaver BA, Grinde E, Mazurkiewicz JE. Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J Biol Chem 2006;281:27109–16.
   PubMed Web of Science ®Google Scholar
• Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999;399:697–700.
   PubMed Web of Science ®Google Scholar
• Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, Portoghese PS, Whistler JL. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 2005;102:9050–5.
   PubMed Web of Science ®Google Scholar
• George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O’Dowd BF. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000;275:26128–35.
   PubMed Web of Science ®Google Scholar
• Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 2004;101:5135–9.
   PubMed Web of Science ®Google Scholar
• AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 2000;407:94–8.
   PubMed Web of Science ®Google Scholar
• Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, Martinez AC. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 2001;20:2497–507.
   PubMed Web of Science ®Google Scholar
• Jiang H, Bentancourt L, Smith RG. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 2006;20:1772–85.
   PubMedGoogle Scholar
• Sartania N, Appelbe S, Pediani JD, Milligan G. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor. Cell Signal 2007;19:1928–38.
   PubMed Web of Science ®Google Scholar
• Terrillon S, Barberis C, Bouvier M. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci U S A 2004:101:1548–53.
   PubMed Web of Science ®Google Scholar
• Baneres JL, Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 2003;329:815–29.
   PubMed Web of Science ®Google Scholar
• Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 2003;278:21655–62.
   PubMed Web of Science ®Google Scholar
• Damian M, Martin A, Mesnier D, Pin JP, Baneres JL. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J 2006;25:5693–702.
   PubMed Web of Science ®Google Scholar
• Damian M, Mary S, Martin A, Pin JP, Baneres JL. G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of transactivation. J Biol Chem 2008;283:21084–92.
   PubMed Web of Science ®Google Scholar
• Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000;289:739–45.
   PubMed Web of Science ®Google Scholar
• Milano SK, Pace HC, Kim YM, Brenner C, Benovic JL. Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry 2002;41:3321–8.
   PubMed Web of Science ®Google Scholar
• Hirsch JA, Schubert C, Gurevich VV, Sigler PB. The 2.8 A crystal structure of visual arrestin: a model for arrestin’s regulation. Cell 1999;97:257–69.
   PubMed Web of Science ®Google Scholar
• Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C. Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure 2001;9:869–80.
   PubMed Web of Science ®Google Scholar
• Vishnivetskiy SA, Hosey MM, Benovic JL, Gurevich VV. Mapping the arrestin-receptor interface.Structural elements responsible for receptor specificity of arrestin proteins. J Biol Chem 2004;279:1262–8.
   PubMed Web of Science ®Google Scholar
• Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem 2007;282:14875–81.
   PubMed Web of Science ®Google Scholar
• Whorton MR, Bokoch MP, Rasmussen SG, Huang B, Zare RN, Kobilka B, Sunahara RK. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A 2007;104:7682–7.
   PubMed Web of Science ®Google Scholar
• Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996;271:16384–92.
   PubMed Web of Science ®Google Scholar
• Monnot C, Bihoreau C, Conchon S, Curnow KM, Corvol P, Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding,and coupling.Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem 1996;271:1507–13.
   PubMed Web of Science ®Google Scholar
• Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A 2000;97:3684–9.
   PubMed Web of Science ®Google Scholar
• Jensen AA, Hansen JL, Sheikh SP, Brauner-Osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). Eur J Biochem 2002;269:5076–87.
   PubMedGoogle Scholar
• Ramsay D, Kellett E, McVey M, Rees S, Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J 2002;365:429–40.
   PubMed Web of Science ®Google Scholar
• McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, Milligan G. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 2001;276:14092–14099.
   PubMed Web of Science ®Google Scholar
• Liu J, Maurel D, Etzol S, Brabet I, Ansanay H, Pin JP, Rondard P. Molecular determinants involved in the allosteric control of agonist affinity in the GABAB receptor by the GABAB2 subunit. J Biol Chem 2004;279:15824–15830.
   PubMed Web of Science ®Google Scholar
• Mijares A, Lebesgue D, Wallukat G, Hoebeke J. From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists. Mol Pharmacol 2000;58:373–9.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, Albar JP, Martinez AC, Mellado M. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci U S A 1999;96:3628–33.
   PubMed Web of Science ®Google Scholar
• Dorsch S, Klotz KN, Engelhardt S, Lohse MJ, Bünemann M. Analysis of receptor oligomerization by FRAP microscopy. Nat Methods 2009;6:225–30.
   PubMed Web of Science ®Google Scholar
• Kubale V, Pogačnik A, Schwartz TW, Vrecl M. Seven transmembrane receptors (7TM) receptors in the view of dimerization and experimental methods to study their dimerization and cross-talk. Slo Vet Res 2008;3:89–102.
   Google Scholar
• James JR, Oliveira MI, Carmo AM, Iaboni A, Davis SJ. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat Methods 2006;3:1001–6.
   PubMed Web of Science ®Google Scholar
• Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prezeau L, Pin JP. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol 2004;11:706–13.
   PubMed Web of Science ®Google Scholar
• Zhang YP, Lewis RN, Henry GD, Sykes BD, Hodges RS, McElhaney RN. Peptide models of helical hydrophobic transmembrane segments of membrane proteins. 1. Studies of the conformation, intrabilayer orientation, and amide hydrogen exchangeability of Ac-K2-(LA)12-K2-amide. Biochemistry 1995;34:2348–61.
   PubMed Web of Science ®Google Scholar
• Sipos L, von Heijne G. Predicting the topology of eukaryotic membrane proteins. Eur J Biochem 1993;213:1333–40.
   PubMedGoogle Scholar
• Johansen TE, Scholler MS, Tolstoy S, Schwartz TW. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett 1990;267:289–94.
   PubMed Web of Science ®Google Scholar
• Chen CA, Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 1988;6:632–38.
   PubMed Web of Science ®Google Scholar
• Elling CE, Thirstrup K, Holst B, Schwartz TW. Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. Proc Natl Acad Sci U S A 1999;96:12322–7.
   PubMed Web of Science ®Google Scholar
• Holst B, Elling CE, Schwartz TW. Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor. Mol Pharmacol 2000;58:263–70.
   PubMed Web of Science ®Google Scholar
• Holst B, Hastrup H, Raffetseder U, Martini L, Schwartz TW. Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J Biol Chem 2001;276:19793–9.
   PubMed Web of Science ®Google Scholar
• Krebs A, Edwards PC, Villa C, Li J, Schertler GFX. The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J Biol Chem 2003;278:50217–25.
   PubMed Web of Science ®Google Scholar
• Hall RA, Premont RT, Chow CW, Blitzer JT, Pitcher JA, Claing A, Stoffel RH, Barak LS, Shenolikar S, Weinman EJ, Grinstein S, Lefkowitz RJ. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998;392:626–30.
   PubMed Web of Science ®Google Scholar
• Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88–91.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Kobilka B. The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc Natl Acad Sci U S A 2003;100:10776–81.
   PubMed Web of Science ®Google Scholar
• Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999;401:286–90.
   PubMed Web of Science ®Google Scholar
• Hung AY, Sheng M. PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002;277:5699–702.
   PubMed Web of Science ®Google Scholar
• Bouvier M, Hausdorff WP, De Blasi A, O’Dowd BF, Kobilka BK, Caron MG, Lefkowitz RJ. Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature 1988;333:370–3.
   PubMed Web of Science ®Google Scholar
• Kubale V, Abramovic Z, Pogacnik A, Heding A, Sentjurc M, Vrecl M. Evidence for a role of caveolin-1 in neurokinin-1 receptor plasma-membrane localization, efficient signaling, and interaction with beta-arrestin 2. Cell Tissue Res 2007;330:231–45.
   PubMed Web of Science ®Google Scholar
• Monastyrskaya K, Hostettler A, Buergi A, Draeger A. The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J Biol Chem 2005;280:7135–46.
   PubMed Web of Science ®Google Scholar
• Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae.A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000;275:41447–41457.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Rybin VO, Steinberg SF, Kobilka B. Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 2002;277:34280–6.
   PubMed Web of Science ®Google Scholar
• Pontier SM, Percherancier Y, Galandrin S, Breit A, Gales C, Bouvier M. Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signalling efficacy: insight into nanoscale organization of signal transduction. J Biol Chem 2008;283: 24659–72.
   PubMed Web of Science ®Google Scholar
• Oh P, Schnitzer JE. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell 2001;12:685–98.
   PubMed Web of Science ®Google Scholar
• Meyer BH, Segura JM, Martinez KL, Hovius R, George N, Johnsson K, Vogel H. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc Natl Acad Sci U S A 2006;103:2138–43.
   PubMed Web of Science ®Google Scholar
• Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, Schroder H, Hollt V, Schulz S. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 2003;278:51630–7.
   PubMed Web of Science ®Google Scholar